Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis (EpiCardiAL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by IRCCS Policlinico S. Matteo
Sponsor:
Information provided by (Responsible Party):
Giampaolo Merlini, IRCCS Policlinico S. Matteo
ClinicalTrials.gov Identifier:
NCT01511263
First received: January 10, 2012
Last updated: February 24, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)